35 related articles for article (PubMed ID: 9315475)
21. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
Joyce DA; Steer JH
Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
24. Soluble immunological markers of disease activity in tuberculosis.
Saltini C; Colizzi V
Eur Respir J; 1999 Sep; 14(3):485-6. PubMed ID: 10543263
[No Abstract] [Full Text] [Related]
25. Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression.
Joyce DA; Kloda A; Steer JH
Immunol Cell Biol; 1997 Aug; 75(4):345-50. PubMed ID: 9315475
[TBL] [Abstract][Full Text] [Related]
26. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes.
Nicod LP; Galve-De-Rochemonteix B; Dayer JM
Ann N Y Acad Sci; 1994 May; 725():323-30. PubMed ID: 8031004
[No Abstract] [Full Text] [Related]
27. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion.
Joyce DA; Steer JH; Abraham LJ
Inflamm Res; 1997 Nov; 46(11):447-51. PubMed ID: 9427064
[TBL] [Abstract][Full Text] [Related]
28. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis.
Dayer JM
Joint Bone Spine; 2002 Mar; 69(2):123-32. PubMed ID: 12027302
[TBL] [Abstract][Full Text] [Related]
29. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
Diez-Ruiz A; Tilz GP; Zangerle R; Baier-Bitterlich G; Wachter H; Fuchs D
Eur J Haematol; 1995 Jan; 54(1):1-8. PubMed ID: 7859870
[TBL] [Abstract][Full Text] [Related]
30. The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.
Abe Y; Watanabe Y; Kimura S
Surg Today; 1994; 24(3):197-202. PubMed ID: 8003860
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
